The recalled ibuprofen tablets may contain individual blistered doses labeled as oxcarbazepine tablets. AHP also recalled the oxcarbazepine tablets due to a mislabeled blister packaging which could result in patients receiving ibuprofen instead.
If a patient misses a dose of oxcarbazepine, used to treat certain type of epileptic seizures, the risk for a seizure increases. Additionally, if a patient accidently consumes ibuprofen, it may cause adverse reactions, according to the U.S. Food and Drug Administration notification regarding the recall.
More Articles on Recalls:
Baxter Initiates Worldwide Saline Solution Recall
5 Health IT Safety Issues Hospital Executives Should Monitor
OR Implants and the Case for Supply Chain Automation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
